Abstract | OBJECTIVE: The purpose of this study was to compare the effectiveness and tolerability of tranylcypromine and combination treatment with extended-release venlafaxine and mirtazapine in patients with treatment-resistant major depression whose current depressive episode had not responded adequately to treatment in three prior prospective medication trials. METHOD: Adult outpatients with nonpsychotic major depressive disorder who had not achieved remission or had withdrawn from treatment because of intolerance in three previous prospective medication trials were randomly assigned to receive open-label treatment with either tranylcypromine (N=58) or extended-release venlafaxine plus mirtazapine (N=51). The primary outcome measure was whether patients achieved remission, which was defined as a score < or =7 at exit on the 17-item Hamilton Depression Rating Scale (HAM-D). The HAM-D was administered by telephone by raters to whom treatment was masked. RESULTS: CONCLUSIONS:
|
Authors | Patrick J McGrath, Jonathan W Stewart, Maurizio Fava, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Michael E Thase, Lori Davis, Melanie M Biggs, Kathy Shores-Wilson, James F Luther, George Niederehe, Diane Warden, A John Rush |
Journal | The American journal of psychiatry
(Am J Psychiatry)
Vol. 163
Issue 9
Pg. 1531-41; quiz 1666
(Sep 2006)
ISSN: 0002-953X [Print] United States |
PMID | 16946177
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antidepressive Agents
- Antidepressive Agents, Second-Generation
- Antidepressive Agents, Tricyclic
- Cyclohexanols
- Delayed-Action Preparations
- Mianserin
- Tranylcypromine
- Venlafaxine Hydrochloride
- Mirtazapine
|
Topics |
- Adult
- Antidepressive Agents
(adverse effects, therapeutic use)
- Antidepressive Agents, Second-Generation
(therapeutic use)
- Antidepressive Agents, Tricyclic
(therapeutic use)
- Cyclohexanols
(therapeutic use)
- Delayed-Action Preparations
- Depressive Disorder, Major
(drug therapy, psychology)
- Drug Administration Schedule
- Drug Resistance
- Drug Therapy, Combination
- Female
- Humans
- Interviews as Topic
- Male
- Mianserin
(analogs & derivatives, therapeutic use)
- Middle Aged
- Mirtazapine
- Psychiatric Status Rating Scales
(statistics & numerical data)
- Tranylcypromine
(adverse effects, therapeutic use)
- Treatment Outcome
- Venlafaxine Hydrochloride
|